Autor segons l'article: Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuende Melero JI; Díaz-Díaz JL; Fernández Pardo J; Guijarro C; Jericó C; Laclaustra M; Lahoz C; López-Miranda J; Martínez-Hervás S; Muñiz-Grijalvo O; Páramo JA; Pascual V; Pedro-Botet J; Pérez-Martínez P; Plana N; Puzo J; Sánchez Chaparro M; Vila L
Departament: Medicina i Cirurgia
Autor/s de la URV: Masana Marín, Luis / Plana Gil, Núria
Paraules clau: Smoking Dyslipidaemia Diabetes Coronary-artery calcium Cardiovascular prevention Atrial fibrillation Arterial hypertension task-force spanish society smoking familial hypercholesterolemia dyslipidaemia diabetes consensus document clinical-practice blood-pressure atrial-fibrillation atrial fibrillation arteriosclerosis sea arterial hypertension american-college
Resum: One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation.
Àrees temàtiques: Pharmacology (medical) Peripheral vascular disease Medicina iii Medicina i Cardiology and cardiovascular medicine
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: luis.masana@urv.cat
Identificador de l'autor: 0000-0002-0789-4954
Data d'alta del registre: 2024-08-24
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.sciencedirect.com/science/article/pii/S0214916821001571?via%3Dihub
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Clinica E Investigacion En Arteriosclerosis. 34 (3): 130-179
Referència de l'ítem segons les normes APA: Mostaza JM; Pintó X; Armario P; Masana L; Real JT; Valdivielso P; Arrobas-Velilla T; Baeza-Trinidad R; Calmarza P; Cebollada J; Civera-Andrés M; Cuend (2022). SEA 2022 Standards for Global Control of Cardiovascular Risk. Clinica E Investigacion En Arteriosclerosis, 34(3), 130-179. DOI: 10.1016/j.arteri.2021.11.003
DOI de l'article: 10.1016/j.arteri.2021.11.003
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2022
Tipus de publicació: Journal Publications